Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Australian Prescriber
|
January 24, 2019
Insulin pumps in general practice
Barbora Paldus, Melissa H Lee, David N O'Neal
JBMR Plus
|
October 5, 2018
Bilateral Avascular Necrosis of the Femoral Head in Fibrous Dysplasia
Melissa H Lee, Peter R Ebeling, Frances Milat
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 2, 2026
Continuing automated insulin delivery systems during hospitalisation with type 1 diabetes: A thematic literature review
Hannah Cunningham, Alicia Jenkins, David N O'Neal, et al.
The Medical Journal of Australia
|
September 29, 2017
Hyponatraemia and hypopituitarism: an easily missed entity
Melissa H Lee, Genevieve L Calder, Richard J MacIsaac, et al.
Journal of Diabetes Science and Technology
|
February 19, 2024
Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index
Melissa H Lee, Sara Vogrin, Timothy W Jones, et al.
Internal Medicine Journal
|
January 10, 2018
Diabetic ketoacidosis in adult patients: an audit of factors influencing time to normalisation of metabolic parameters
Melissa H Lee, Genevieve L Calder, John D Santamaria, et al.
Endocrinology, Diabetes & Metabolism Case Reports
|
May 5, 2017
An intrasellar pituitary adenoma-gangliocytoma presenting as acromegaly
Melissa H Lee, Penelope McKelvie, Balasubramanian Krishnamurthy, et al.
Pediatric Emergency Care
|
August 4, 2012
Functional outcome after air-stirrup ankle brace or fiberglass backslab for pediatric low-risk ankle fractures: a randomized observer-blinded controlled trial
Peter Leslie John Barnett, Melissa H Lee, Luke Oh, et al.
Diabetes Research and Clinical Practice
|
May 29, 2025
Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes. Part B: Risks of sodium-glucose co-transporter inhibitor use in type 1 diabetes and ketoacidosis risk mitigation strategies
Jennifer Ngan, David N O'Neal, Melissa H Lee, et al.
Internal Medicine Journal
|
January 12, 2017
Aceruloplasminaemia: a disorder of diabetes and neurodegeneration
Genevieve L Calder, Melissa H Lee, Nirupa Sachithanandan, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Australian Prescriber
|
January 24, 2019
Insulin pumps in general practice
Barbora Paldus, Melissa H Lee, David N O'Neal
JBMR Plus
|
October 5, 2018
Bilateral Avascular Necrosis of the Femoral Head in Fibrous Dysplasia
Melissa H Lee, Peter R Ebeling, Frances Milat
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 2, 2026
Continuing automated insulin delivery systems during hospitalisation with type 1 diabetes: A thematic literature review
Hannah Cunningham, Alicia Jenkins, David N O'Neal, et al.
The Medical Journal of Australia
|
September 29, 2017
Hyponatraemia and hypopituitarism: an easily missed entity
Melissa H Lee, Genevieve L Calder, Richard J MacIsaac, et al.
Journal of Diabetes Science and Technology
|
February 19, 2024
Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index
Melissa H Lee, Sara Vogrin, Timothy W Jones, et al.
Internal Medicine Journal
|
January 10, 2018
Diabetic ketoacidosis in adult patients: an audit of factors influencing time to normalisation of metabolic parameters
Melissa H Lee, Genevieve L Calder, John D Santamaria, et al.
Endocrinology, Diabetes & Metabolism Case Reports
|
May 5, 2017
An intrasellar pituitary adenoma-gangliocytoma presenting as acromegaly
Melissa H Lee, Penelope McKelvie, Balasubramanian Krishnamurthy, et al.
Pediatric Emergency Care
|
August 4, 2012
Functional outcome after air-stirrup ankle brace or fiberglass backslab for pediatric low-risk ankle fractures: a randomized observer-blinded controlled trial
Peter Leslie John Barnett, Melissa H Lee, Luke Oh, et al.
Diabetes Research and Clinical Practice
|
May 29, 2025
Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes. Part B: Risks of sodium-glucose co-transporter inhibitor use in type 1 diabetes and ketoacidosis risk mitigation strategies
Jennifer Ngan, David N O'Neal, Melissa H Lee, et al.
Internal Medicine Journal
|
January 12, 2017
Aceruloplasminaemia: a disorder of diabetes and neurodegeneration
Genevieve L Calder, Melissa H Lee, Nirupa Sachithanandan, et al.
Page
of 6